Seeking Clarity: The Myths About Nonclinical and Clinical Trials in Australia

Often when people talk about nonclinical and clinical trials there are a lot of misconceptions and myths about what a clinical trial involves.

Clearing up misunderstandings about the Outback

You’ve heard about the 43.5% R&D tax incentive and expedited timelines when sending studies to Australia, but do you fully understand the process so you can take advantage of it without encountering any pitfalls?

We are bringing together a group of experts to impart their knowledge and share their experiences with global biopharmas choosing the “Australian Advantage.”